The 131st Annual Meeting (November 15-19, 2003) of APHA

Abstract #62569

Manon A. Boudreault, MPH¹, Leda Gbetibouo, MPH¹, and Richard J. Klein, MPH². (1) Office of Analysis, Epidemiology, and Health Promotion, National Center for Health Statistics, 3311 Toledo Road, Room 6319, Hyattsville, MD 20782, (2) Office of Analysis, Epidemiology and Health Promotion, National Center for Health Statistics, CDC, 3311 Toledo Road, Room 6317, Hyattsville, MD 20782

About 17 million Americans have diabetes and annually, there are over 200,000 deaths per year and costs of about $100 billion dollars due to diabetes. Projected prevalence estimates due to aging of the population and increasing prevalence rates show that by 2025, unabated, 21 million people in the U.S. could have diabetes. Research has shown that self–management and provider services can impact diabetes development, morbidity and mortality. This presentation shows how the Healthy People data measures can be used to monitor prevention efforts, and disease progression and development. Examples of statistical issues in the calculation of diabetes incidence, prevalence, and reporting of diabetes deaths will be presented.

Learning Objectives:

Participant will be able to:
• Select a variety of data measures to track prevention efforts and public health impact of diabetes.
• Identify extent of the diabetes burden (economic, prevalence, incidence) and future projections for diabetes prevalence.
• Identify important statistical issues in the interpretation of diabetes deaths, and methodologies used in calculating diabetes incidence and prevalence.
• Identify the age adjustment procedure used in the calculation of chronic disease measures and the effect of varying age groups used in the procedure.
• Identify state source of diabetes and prevention data that could be used to monitor prevention efforts.
• Identify racial/ethnic disparities to better target prevention efforts.
• Identify diabetes prevention and management efforts within Health and Human Services.

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.